Explore satellite symposia

Satellite symposia during Scientific Sessions 2020 provide a unique opportunity for companies to share their latest advances in cardiovascular practices, services and technologies.


Getty Images 1180547354 5

Here are the daily symposia. Check the “AHA Conferences” Mobile App for a complete list of updated programming.

Friday, Nov. 13

5-6:30 p.m. CST
Getting to the Heart of Diabetes: The Role of GLP-1 Receptor Agonists in Reducing Cardiovascular Risk (SS.07)

Panel Participants: 

Richard E. Pratley, MD

Darren McGuire, MD, MHSC

Sponsored by Lilly


5-6:30 p.m. CST
Optimizing Outcomes in VTE Management: Collaborating Across the Continuum (SS.11)

Panel Participants:

Charles Vega MD, FAAFP

Elaine Hylek, MD, MPH

Deepak Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

Gregory Piazza, MD, MS

Sponsored by The Bristol-Myers Squibb and Pfizer Alliance     


Saturday, Nov. 14

3:30-4:15 p.m. CST
A New Horizon to Optimize AF Outcomes: Emerging Data and Techniques in Hybrid Ablation (SS.04)

Panel Participants:

David DeLurgio, MD, FACC, FHRS

Felix Yang, MD, FACC, FHRS, CCDS

Faraz Kerendi, MD

Sponsored by AtriCure


5-6:30 p.m. CST
The Heart, the Kidney and SGLT2 Inhibition: From Clinical Trials to Patient Care (SS.06)

Panel Participants:

Mikhail Kosiborod, MD

John McMurray, MB, ChB (Hons), MD

Marc Sabatine, MD, MPH

Robert Toto, MD

Sponsored by AstraZeneca Pharmaceuticals


5-6:30 p.m. CST
Thrombosis and Prevention in COVID-19: What Are We Missing? (SS.10)

Sponsored by CPC Clinical Research  


5-6:30 p.m. CST
Identifying Undiagnosed Nonvalvular Atrial Fibrillation in the Age of Telehealth: Novel Screening Technologies and Stroke Prevention Strategies (SS.12)

Panel Participants:

Christian T. Ruff, MD, MPH 

Mintu Turakhia, MD, MS

Sponsored by Bristol-Myers Squibb and Pfizer Alliance


Sunday, Nov. 15

1:30-2:15 p.m. CST
Calcitropes, Myotropes and Mitotropes: The Role of Emerging Therapies to Improve Systolic Function in HFrEF (SS.02)

Panelist:

John R. Teerlink, MD

Sponsored by Cytokinetics, Inc.


5-6:30 p.m. CST
Addressing the Impacts of Iron Deficiency in HF: Advances in Diagnosis and Management (SS.08)

Panel Participants:

Biykem Bozkurt, MD, PhD, FACC, FAHA 

Gurusher S. Panjrath, MD, FACC, FAHA

Sponsored by American Regent


5-6:30 p.m. CST
Improving Cardiovascular Outcomes by Decreasing Residual Risk (SS.13)

Panel Participants:

Pamela B. Morris, MD 

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC   

Ann Marie Navar, MD, PhD

Sponsored by Amarin Pharma Inc.


5-6:45 p.m. CST
National Heart, Lung, and Blood Institute (NHLBI) Company Showcase (SS.09)

Sponsored by National Heart, Lung, and Blood Institute


Monday, Nov. 16

3:30-4:15 p.m. CST
Mayo Clinic Cardiac Surgery Expertise in Surgical Treatment of Hypertrophic Cardiomyopathy, Aortic Aneurysms and Robotic Heart Surgery (SS.16)

Panel Participants:

Arman Arghami, MD

Gabor Bagameri, MD

Phillip Rowse, MD

Sponsored by Mayo Clinic Department of Cardiovascular Surgery


5-6:30 p.m. CST

Getting to the Heart of Diabetes: The Role of GLP-1 Receptor Agonists in Reducing Cardiovascular Risk  

Panel Participants: 
Darren McGuire, MD
Richard Pratley, MD

Sponsored by Lilly


5-6:30 p.m. CST

Antiplatelet Agent Updates: From Primary Prevention in CAD to Secondary Prevention of Stroke (SS.01)

Panel Participants:

Dominick J. Angiolillo, MD, PhD

Deepak L. Bhatt, MD, MPH

S. Claiborne Johnston, MD, PhD

Sponsored by AstraZeneca


5-6:30 p.m. CST
Lowering LDL-C: When Statins Aren’t Enough (SS.14)

Panel Participants:

Christie M. Ballantyne, MD

Pamela B. Morris, MD, FNLA

Sponsored by ESPERION Therapeutics, Inc.  


Tuesday, Nov. 17

1:30 p.m. CST

Optimizing Outcomes in VTE Management: Collaborating Across the Continuum

Panel Participants:
Charles Vega, MD
Elaine Hylek, MD, MPH
Gregory Piazza, MD

Sponsored by Bristol-Myers Squibb and Pfizer Alliance

5-6:30 p.m. CST
Stepping Up Your Game for Management of Dyslipidemia (SS.03)

Panel Participants:

Seth J. Baum, MD

Alan S. Brown, MD

Marc S. Sabatine, MD, MPH

Sponsored by Amgen


5-6:30 p.m. CST
The Role of Anticoagulants for Secondary Prevention in CAD and PAD Patients: When Should Therapy Be Initiated? (SS.15)

Panel Participants:

Deepak Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

Kelley Branch, MD, MS

Keith C. Ferdinand, MD, FACC ,FAHA , FASPC, FNLA

Sonia Anand, MD, PhD

Sponsored by Janssen Scientific Affairs, LLC


These events are not part of the official Scientific Sessions as planned by the AHA Committee on Scientific Sessions Programming.